Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 471Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2APOTEX INC

02 2BAUSCH HEALTH, CANADA INC.

03 2JAMP PHARMA CORPORATION

04 2MINT PHARMACEUTICALS INC

05 2PHARMASCIENCE INC

06 2PRO DOC LIMITEE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

ZOLPIDEM TARTRATE

Brand Name : APO-ZOLPIDEM ODT

Dosage Form : TABLET (ORALLY DISINTEGRATING)

Dosage Strength : 10MG

Packaging : 30/100/500

Approval Date :

Application Number : 2434946

Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

Registration Country : Canada

blank

02

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

ZOLPIDEM TARTRATE

Brand Name : APO-ZOLPIDEM ODT

Dosage Form : TABLET (ORALLY DISINTEGRATING)

Dosage Strength : 5MG

Packaging : 30/100/500

Approval Date :

Application Number : 2436159

Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

Registration Country : Canada

blank

03

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

ZOLPIDEM TARTRATE

Brand Name : SUBLINOX

Dosage Form : TABLET (ORALLY DISINTEGRATING)

Dosage Strength : 10MG

Packaging : 10/30/100

Approval Date :

Application Number : 2370433

Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

Registration Country : Canada

blank

04

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

ZOLPIDEM TARTRATE

Brand Name : SUBLINOX

Dosage Form : TABLET (ORALLY DISINTEGRATING)

Dosage Strength : 5MG

Packaging : 10/30/100

Approval Date :

Application Number : 2391678

Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

Registration Country : Canada

blank

05

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

ZOLPIDEM TARTRATE

Brand Name : MINT-ZOLPIDEM ODT

Dosage Form : TABLET (ORALLY DISINTEGRATING)

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number : 2472821

Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

Registration Country : Canada

blank

06

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

ZOLPIDEM TARTRATE

Brand Name : MINT-ZOLPIDEM ODT

Dosage Form : TABLET (ORALLY DISINTEGRATING)

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number : 2472848

Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

Registration Country : Canada

blank

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

ZOLPIDEM TARTRATE

Brand Name : PMS-ZOLPIDEM ODT

Dosage Form : TABLET (ORALLY DISINTEGRATING)

Dosage Strength : 5MG

Packaging : 30

Approval Date :

Application Number : 2436175

Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

Registration Country : Canada

blank

08

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

ZOLPIDEM TARTRATE

Brand Name : PMS-ZOLPIDEM ODT

Dosage Form : TABLET (ORALLY DISINTEGRATING)

Dosage Strength : 10MG

Packaging : 30

Approval Date :

Application Number : 2436183

Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

Registration Country : Canada

blank

09

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

ZOLPIDEM TARTRATE

Brand Name : PRO-ZOLPIDEM ODT

Dosage Form : TABLET (ORALLY DISINTEGRATING)

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number : 2537346

Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

Registration Country : Canada

blank

10

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

ZOLPIDEM TARTRATE

Brand Name : PRO-ZOLPIDEM ODT

Dosage Form : TABLET (ORALLY DISINTEGRATING)

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number : 2537354

Regulatory Info : TARGETED SUBSTANCES (CDSA IV)

Registration Country : Canada

blank